Nupal Remedies Private Limited, a active private limited company, was established on 17 June 1994 in Ernakulam, Kerala, India. Engaging in online healthcare product retail within the manufacturing sector, it holds CIN: U24231KL1994PTC007989. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹8.00 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Thuruthippallil Padmanabhan Sachith Roy (Whole-Time Director), Udayakumar Padmanabhan (Whole-Time Director), Krishna Kumar Padmanabhan (Managing Director). It holds ₹5.74 Cr open charges and ₹4.75 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P B No 2051Raveendran Road Kochi, Ernakulam, Kerala, 682020.
U24231KL1994PTC007989
007989
17 June 1994
₹8.00 M
₹8.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Nupal Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thuruthippallil Padmanabhan Sachith Roy | Whole-Time Director | 17 Jun 1994 | Current |
| Udayakumar Padmanabhan | Whole-Time Director | 30 Jun 2000 | Current |
| Krishna Kumar Padmanabhan | Managing Director | 17 Jun 1994 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nupal Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.33% increase. The company also saw a substantial improvement in profitability, with a 2790.81% increase in profit. The company's net worth Soared by an impressive increase of 83.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Nupal Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹57,375,000.00
₹4,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2021 | Canara Bank | ₹1.09 Cr | Open |
| 30 Oct 2021 | Canara Bank | ₹2.17 M | Open |
| 16 Sep 2021 | Canara Bank | ₹1.05 Cr | Open |
| 25 Mar 2019 | Canara Bank | ₹1.00 M | Open |
| 30 Dec 2017 | Canara Bank | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Nupal Remedies has a workforce of 21 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nupal Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nupal Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 30 Mar 2022 via Charge ID 100564477 with Canara Bank was fully satisfied on 25 Feb 2025. was completed.
The activity Nupal Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Nupal Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
A charge with Canara Bank of Rs. 10.00 M registered on 30 Dec 2017 with Charge ID 100157451 was modified on 21 Mar 2023. was recorded as a recent event.
The activity A charge with Canara Bank amounted to Rs. 2.80 M with Charge ID 100564477 was registered on 30 Mar 2022. was completed.
The activity A charge with Canara Bank amounted to Rs. 10.90 M with Charge ID 100535314 was registered on 01 Dec 2021. was completed.
The CIN of Nupal Remedies Private Limited is U24231KL1994PTC007989.
Nupal Remedies Private Limited is headquartered at P B No 2051Raveendran Road Kochi, Ernakulam, Kerala, 682020.
Nupal Remedies Private Limited was incorporated on 17 June 1994.
The current directors of Nupal Remedies Private Limited are
The primary industry of Nupal Remedies Private Limited is Manufacturing.
Nupal Remedies Private Limited is unlisted.
The authorized capital of Nupal Remedies Private Limited is ₹8.00 M, and the paid-up capital is ₹8.00 M.
The compliance status of Nupal Remedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX